Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.

Volume: 57, Issue: 10, Pages: 1617 - 1624
Published: Oct 1, 2016
Abstract
SummaryObjective Tuberous sclerosis complex (TSC) is an autosomal-dominant genetic disorder with highly variable expression. The most common neurologic manifestation of TSC is epilepsy, which affects approximately 85% of patients, 63% of whom develop treatment-resistant epilepsy. Herein, we evaluate the efficacy, safety, and tolerability of cannabidiol (CBD), a nonpsychoactive compound derived from the marijuana plant, as an adjunct to current...
Paper Details
Title
Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.
Published Date
Oct 1, 2016
Journal
Volume
57
Issue
10
Pages
1617 - 1624
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.